Johnson & Johnson(JNJ)NASDAQ
Stock Performance & Returns
Peer Comparison
Relative scale, growth, and profitability vs sector peers
| Ticker | Market Cap | P/E Ratio | Revenue Growth | Net Margin | EPS | ROE | Debt/Equity | Dividend Yield | 52W High | 52W Low |
|---|---|---|---|---|---|---|---|---|---|---|
JNJ | 670.99 B | 32.53x | 6.60% | 21.48% | $8.56 | 25.74% | 0.58 | 2.00% | $275.11 | $169.51 |
LLY | 1.03 T | 38.86x | 47.70% | 33.53% | $29.84 | 1.02% | 1.62 | 59.00% | $1292.65 | $707.59 |
ABBV | 459.82 B | 73.30x | 10.20% | 9.80% | $3.55 | - | - | 2.71% | $267.47 | $189.40 |
MRK | 375.85 B | 121.87x | 5.10% | 4.77% | $1.25 | 6.96% | 1.28 | 2.29% | $156.92 | $75.81 |
AZN | 255.54 B | 24.63x | 6.40% | 17.02% | $6.69 | 21.97% | 0.64 | 1.96% | $210.52 | $144.30 |
NVO | 158.93 B | 11.62x | 2.10% | 35.35% | $4.09 | 59.82% | 0.63 | 3.96% | $61.11 | $34.15 |
Peer Valuation & Performance Analysis
Peer group analysis for Johnson & Johnson (JNJ) compared to its primary competitors (including LLY, ABBV, MRK) reveals distinct metrics. JNJ trades at a valuation discount relative to its competitors, with a P/E ratio of 32.5x versus the peer average of 51.7x (representing a 37% discount). This discount might represent an undervalued entry opportunity or reflect specific risk factors the market is discounting. In terms of growth, JNJ's revenue growth of 6.6% lags behind the peer average of 12.5%, indicating potential market share losses or slower industry adoption. Additionally, it boasts superior profitability with a net margin of 21.5% compared to the peer average of 18.1%, demonstrating strong cost controls and pricing power.
Peer Performance Rankings
Ranking comparison across key performance metrics
P/E Ratio (Lower is Better)
Revenue Growth
Net Profit Margin
Financial Rankings Summary
• JNJ ranks #2 in P/E ratio, #3 in revenue growth, and #2 in profit margins
• Average ranking: #2 - 🎯 Top-tier fundamentals relative to peer group
• Rankings based on actual financial data from company reports
Historical Trading Data
Price and volume data with customizable timeframes
Showing 15 of 15 trading sessions from the last 15 days
| Date | Open | High | Low | Close | Volume | Daily Change |
|---|---|---|---|---|---|---|
| 2026-09-03 | $277.32 | $278.89 | $273.16 | $278.43 | 5,940,300 | +0.40% |
| 2026-09-02 | $274.74 | $281.07 | $273.53 | $275.21 | 7,910,600 | +0.17% |
| 2026-09-01 | $270.83 | $271.91 | $267.02 | $271.19 | 6,033,600 | +0.13% |
| 2026-08-31 | $267.13 | $267.77 | $265.17 | $265.85 | 7,900,100 | -0.48% |
| 2026-08-28 | $265.78 | $268.38 | $264.27 | $268.04 | 5,765,600 | +0.85% |
| 2026-08-27 | $268.45 | $268.45 | $263.83 | $265.77 | 7,306,200 | -1.00% |
| 2026-08-26 | $271.97 | $272.91 | $269.55 | $270.00 | 7,214,100 | -0.72% |
| 2026-08-25 | $271.00 | $273.80 | $270.18 | $273.14 | 4,687,000 | +0.79% |
| 2026-08-24 | $268.42 | $272.64 | $267.25 | $271.70 | 5,436,100 | +1.22% |
| 2026-08-21 | $266.52 | $271.32 | $265.69 | $268.91 | 6,186,800 | +0.90% |
| 2026-08-20 | $273.40 | $273.40 | $267.37 | $267.37 | 6,475,900 | -2.21% |
| 2026-08-19 | $273.00 | $276.47 | $270.56 | $273.41 | 7,725,500 | +0.15% |
| 2026-08-18 | $267.67 | $271.73 | $266.33 | $271.11 | 7,835,500 | +1.29% |
| 2026-08-17 | $258.87 | $264.28 | $258.01 | $262.37 | 5,515,500 | +1.35% |
| 2026-08-14 | $260.65 | $261.71 | $259.16 | $260.35 | 4,998,100 | -0.12% |
Explore More Analysis for JNJ
Additional research, tools, and technical breakdowns
Stock Analyzer Report
Deep-dive automated research and stock rating report.
DCF Fair Value Calculator
Discounted cash flow model and intrinsic value projection.
AI Price Predictions
Multi-scenario price predictions and consensus targets.
Insider Activity Tracker
Track buying/selling behavior of corporate insiders.
Earnings Calendar
Track upcoming and historical corporate earnings reports.
Market Insights & Research
Read the latest analysis articles and expert research.